Main menu

HLA typing using targeted third-generation sequencing methods


Abstract

Detailed typing of the extremely variable human leukocyte antigens (HLA) is necessary to check for transplantation compatibility and to investigate auto-immune disorders. Nanopore sequencing allows detailed typing with reduced levels of sequencing artefacts, costs, and workload. The longer reads also reduce the complexity of the downstream data analysis. On top of that, targeted sequencing strategies for nanopore sequencing allows specific enrichment of long reads in the different HLA regions without using PCR. Two approaches of targeted sequencing were demonstrated to yield major advantages for HLA typing: CRISPR/Cas9 enrichment and adaptive sampling.

Authors: Steven Verbruggen

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag